138 related articles for article (PubMed ID: 22538023)
21. Letter to the editor: Re: Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
Dubinsky RM
Clin Rehabil; 2010 Aug; 24(8):766. PubMed ID: 20702516
[No Abstract] [Full Text] [Related]
22. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
Desai MJ; Shkolnikova T; Nava A; Inwald D
Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
[TBL] [Abstract][Full Text] [Related]
23. The use of botulinum toxin in the treatment of the consequences of bruxism on cervical spine musculature.
Finiels PJ; Batifol D
Toxicon; 2014 Mar; 80():58-63. PubMed ID: 24462662
[TBL] [Abstract][Full Text] [Related]
24. [Bruxism, temporo-mandibular dysfunction and botulinum toxin].
Chikhani L; Dichamp J
Ann Readapt Med Phys; 2003 Jul; 46(6):333-7. PubMed ID: 12928140
[TBL] [Abstract][Full Text] [Related]
25. Neuro-reflexotherapy for the management of myofascial temporomandibular joint pain: a double-blind, placebo-controlled, randomized clinical trial.
Berguer A; Kovacs F; Abraira V; Mufraggi N; Royuela A; Muriel A; Gestoso M; Falahat F; Martín-Granizo R; Zamora J
J Oral Maxillofac Surg; 2008 Aug; 66(8):1664-77. PubMed ID: 18634956
[TBL] [Abstract][Full Text] [Related]
26. Treatment of temporomandibular disorders with botulinum toxin.
Schwartz M; Freund B
Clin J Pain; 2002; 18(6 Suppl):S198-203. PubMed ID: 12569969
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction.
Awan KH; Patil S; Alamir AWH; Maddur N; Arakeri G; Carrozzo M; Brennan PA
J Oral Pathol Med; 2019 Mar; 48(3):192-200. PubMed ID: 30604895
[TBL] [Abstract][Full Text] [Related]
28. Acute neuromuscular failure related to long-term botulinum toxin therapy.
Coletti Moja M; Dimanico U; Mongini T; Cavaciocchi V; Gerbino Promis PC; Grasso E
Eur Neurol; 2004; 51(3):181-3. PubMed ID: 15073447
[No Abstract] [Full Text] [Related]
29. [Myofascial pain as the main symptom of the temporomandibular pain dysfunction syndrome--a clinico-experimental study].
Schimek JJ
Schweiz Monatsschr Zahnmed (1984); 1984 Sep; 94(9):801-12. PubMed ID: 6593829
[No Abstract] [Full Text] [Related]
30. The use of botulinum toxin for the treatment of temporomandibular disorder.
Freund B; Schwartz M
Oral Health; 1998 Feb; 88(2):32-7. PubMed ID: 9610334
[No Abstract] [Full Text] [Related]
31. Efficacy of tizanidine hydrochloride in the treatment of myofascial face pain.
Manfredini D; Romagnoli M; Cantini E; Bosco M
Minerva Med; 2004 Apr; 95(2):165-71. PubMed ID: 15272252
[TBL] [Abstract][Full Text] [Related]
32. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
De Laet K; Wyndaele JJ
Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
[TBL] [Abstract][Full Text] [Related]
33. Mandibular Bone Loss after Masticatory Muscles Intervention with Botulinum Toxin: An Approach from Basic Research to Clinical Findings.
Balanta-Melo J; Toro-Ibacache V; Kupczik K; Buvinic S
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30717172
[TBL] [Abstract][Full Text] [Related]
34. Effects of botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections.
Pascali MP; Mosiello G; Boldrini R; Salsano ML; Castelli E; De Gennaro M
J Urol; 2011 Jun; 185(6 Suppl):2552-7. PubMed ID: 21527192
[TBL] [Abstract][Full Text] [Related]
35. Acute myocardial infarction after botulinum toxin injection.
Stähli BE; Altwegg L; Lüscher TF; Corti R
QJM; 2011 Jul; 104(7):615-6. PubMed ID: 20851822
[No Abstract] [Full Text] [Related]
36. Botulinum toxin for the treatment of bruxism.
Tinastepe N; Küçük BB; Oral K
Cranio; 2015 Oct; 33(4):291-8. PubMed ID: 26715152
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin: clinical techniques, applications, and complications.
Stephan S; Wang TD
Facial Plast Surg; 2011 Dec; 27(6):529-39. PubMed ID: 22205526
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type A in children. New indication for limb spasticity.
Prescrire Int; 2011 Mar; 20(114):68. PubMed ID: 21648226
[No Abstract] [Full Text] [Related]
39. The treatment of patients with temporomandibular joint pain dysfunction syndrome.
Zarb GA; Thompson GW
Dent J; 1975 Jul; 41(7):410-7. PubMed ID: 1094024
[No Abstract] [Full Text] [Related]
40. Botulinum toxins in dentistry--the new paradigm for masticatory muscle hypertonicity.
Katz H
Singapore Dent J; 2005 Dec; 27(1):7-12. PubMed ID: 16438262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
